AAAAAA

   
Results: 1-25 |
Results: 25

Authors: MCDONALD AC VASEY PA ADAMS L WALLING J WOODWORTH JR ABRAHAMS T MCCARTHY S BAILEY NP SIDDIQUI N LIND MJ CALVERT AH TWELVES CJ CASSIDY J KAYE SB
Citation: Ac. Mcdonald et al., A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE, Clinical cancer research, 4(3), 1998, pp. 605-610

Authors: MCDONALD AC VASEY PA ADAMS L WALLING J WOODWORTH JR ABRAHAMS T MCCARTHY S BAILEY NP SIDDIQUI N LIND MJ CALVERT AH TWELVES CJ CASSIDY J KAYE SB
Citation: Ac. Mcdonald et al., A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE, Clinical cancer research, 4(3), 1998, pp. 605-610

Authors: TWELVES CJ THOMSON CS YOUNG J GOULD A
Citation: Cj. Twelves et al., ENTRY INTO CLINICAL-TRIALS IN BREAST-CANCER - THE IMPORTANCE OF SPECIALIST TEAMS, European journal of cancer, 34(7), 1998, pp. 1004-1007

Authors: MACLEOD U ROSS S TWELVES CJ GILLIS C WATT GCM
Citation: U. Macleod et al., BREAST-CANCER CARE - DOES THE NHS DISCRIMINATE AGAINST WOMEN LIVING IN DEPRIVED AREAS, European journal of cancer, 34, 1998, pp. 335-335

Authors: WALLACE J TWELVES CJ CANNEY P EVANS J STEWART M MORRISON R SETANOIANS A SCHATZLEIN A
Citation: J. Wallace et al., ORAL IDARUBICIN IN ADVANCED BREAST-CANCER - EVALUATION OF A NEW ORAL SCHEDULE IN ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 140-140

Authors: MILES DW TWELVES CJ EGGLETON SPH BURRELL A HALL A
Citation: Dw. Miles et al., QUALITY-OF-LIFE EFFECTS OF TAXOTERE THERAPY IN 184 PATIENTS WITH ANTHRACYCLINE-PRETREATED METASTATIC BREAST-CANCER, Annals of oncology, 9, 1998, pp. 550-550

Authors: TWELVES CJ DOBBS NA GILLIES HC JAMES CA RUBENS RD HARPER PG
Citation: Cj. Twelves et al., DOXORUBICIN PHARMACOKINETICS - THE EFFECT OF ABNORMAL LIVER BIOCHEMISTRY TESTS, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 229-234

Authors: TWELVES CJ THOMSON CS GOULD A DEWAR JA
Citation: Cj. Twelves et al., VARIATION IN THE SURVIVAL OF WOMEN WITH BREAST-CANCER IN SCOTLAND, British Journal of Cancer, 78(5), 1998, pp. 566-571

Authors: DOBBS NA TWELVES CJ
Citation: Na. Dobbs et Cj. Twelves, WHAT IS THE EFFECT OF ADJUSTING EPIRUBICIN DOSES FOR BODY-SURFACE AREA, British Journal of Cancer, 78(5), 1998, pp. 662-666

Authors: MACLEOD U TWELVES CJ ROSS S GILLIS C WATT GCM
Citation: U. Macleod et al., A COMPARISON OF THE CARE RECEIVED BY WOMEN WITH BREAST-CANCER LIVING IN AFFLUENT AND DEPRIVED AREAS, British Journal of Cancer, 78, 1998, pp. 43-43

Authors: SLUDDEN J SCHATZLEIN AG TETLEY L TWELVES CJ UCHEGBU IF
Citation: J. Sludden et al., DEVELOPMENT OF A BLEOMYCIN POLYMERIC VESICLE FORMULATION, British Journal of Cancer, 78, 1998, pp. 49-49

Authors: MACKEAN MJ CASSIDY J JODRELL DI PAUL J REED NS CANNEY PA YOSEF H HABESHAW T ROBERTSON AG MCINNES A TWELVES CJ
Citation: Mj. Mackean et al., BOLUS INFUSIONAL 5-FLUOROURACIL AND FOLINIC ACID - A REPORT ON 2 PROSPECTIVE, CONSECUTIVE PHASE-II STUDIES WITH 5-FLUOROURACIL DOSE-ESCALATION/, British Journal of Cancer, 77(9), 1998, pp. 1480-1486

Authors: DOBBS NA TWELVES CJ
Citation: Na. Dobbs et Cj. Twelves, ANTHRACYCLINE DOSES IN PATIENTS WITH LIVER DYSFUNCTION - DO UK ONCOLOGISTS FOLLOW CURRENT RECOMMENDATIONS, British Journal of Cancer, 77(7), 1998, pp. 1145-1148

Authors: TWELVES CJ THOMSON CS YOUNG J GOULD A
Citation: Cj. Twelves et al., ENTRY TO BREAST-CANCER CLINICAL-TRIALS - THE IMPORTANCE OF SPECIALISTTREATMENT TEAMS, European journal of cancer, 33, 1997, pp. 347-347

Authors: DOBBS NA TWELVES CJ
Citation: Na. Dobbs et Cj. Twelves, ARE NEW ANTHRACYCLINE DOSE RECOMMENDATIONS NEEDED FOR PATIENTS WITH LIVER DYSFUNCTION, European journal of cancer, 33, 1997, pp. 692-692

Authors: TWELVES CJ VERMORKEN J BOWMAN A SIMPSON A SMYTH J HOPPENER F BEIJNEN J JIMENO J HANAUSKE AR
Citation: Cj. Twelves et al., PHASE-I AND PHARMACOKINETIC STUDY OF ECTEINASCIDIN-743 (ET-743) GIVENAS A ONE-HOUR INFUSION EVERY 21 DAYS, European journal of cancer, 33, 1997, pp. 1107-1107

Authors: DOBBS NA TWELVES CJ GILLIES H JAMES CA HARPER PG RUBENS RD
Citation: Na. Dobbs et al., GENDER AFFECTS DOXORUBICIN PHARMACOKINETICS IN PATIENTS WITH NORMAL LIVER BIOCHEMISTRY, Cancer chemotherapy and pharmacology, 36(6), 1995, pp. 473-476

Authors: DOBBS NA TWELVES CJ
Citation: Na. Dobbs et Cj. Twelves, COMMENTS ON EPIRUBICIN, Annals of oncology, 5(1), 1994, pp. 98-99

Authors: DOBBS NA TWELVES CJ RIZZI P WARWICK JD METIVIER EM WILLIAMS R JOHNSON PJ
Citation: Na. Dobbs et al., EPIRUBICIN IN HEPATOCELLULAR-CARCINOMA - PHARMACOKINETICS AND CLINICAL ACTIVITY, Cancer chemotherapy and pharmacology, 34(5), 1994, pp. 405-410

Authors: TWELVES CJ LOWRY M PORTER DA DOBBS NA GRAVES PE SMITH MA RICHARDS MA
Citation: Cj. Twelves et al., P-31 METABOLISM OF HUMAN BREAST - AN IN-VIVO MAGNETIC-RESONANCE SPECTROSCOPIC STUDY AT 1.5 TESLA, British journal of radiology, 67(793), 1994, pp. 36-45

Authors: TWELVES CJ DOBBS NA CURNOW A COLEMAN RE STEWART AL TYRRELL CJ CANNEY P RUBENS RD
Citation: Cj. Twelves et al., A PHASE-II, MULTICENTER, UK STUDY OF VINORELBINE IN ADVANCED BREAST-CANCER, British Journal of Cancer, 70(5), 1994, pp. 990-993

Authors: TWELVES CJ PORTER DA LOWRY M DOBBS NA GRAVES PE SMITH MA RUBENS RD RICHARDS MA
Citation: Cj. Twelves et al., P-31 METABOLISM OF POSTMENOPAUSAL BREAST-CANCER STUDIED IN-VIVO BY MAGNETIC-RESONANCE SPECTROSCOPY, British Journal of Cancer, 69(6), 1994, pp. 1151-1156

Authors: TWELVES CJ DOBBS NA LAWRENCE MA RAMIREZ AJ SUMMERHAYES M RICHARDS MA TOWLSON KE RUBENS RD
Citation: Cj. Twelves et al., IODODOXORUBICIN IN ADVANCED BREAST-CANCER - A PHASE-II EVALUATION OF CLINICAL ACTIVITY, PHARMACOLOGY AND QUALITY-OF-LIFE, British Journal of Cancer, 69(4), 1994, pp. 726-731

Authors: DOBBS NA TWELVES CJ RAMIREZ AJ TOWLSON KE GREGORY WM RICHARDS MA
Citation: Na. Dobbs et al., PATIENT ACCEPTABILITY AND PRACTICAL IMPLICATIONS OF PHARMACOKINETIC STUDIES IN PATIENTS WITH ADVANCED CANCER, European journal of cancer, 29A(12), 1993, pp. 1707-1711

Authors: GREGORY WM SMITH P RICHARDS MA TWELVES CJ KNIGHT RK RUBENS RD
Citation: Wm. Gregory et al., CHEMOTHERAPY OF ADVANCED BREAST-CANCER - OUTCOME AND PROGNOSTIC FACTORS, British Journal of Cancer, 68(5), 1993, pp. 988-995
Risultati: 1-25 |